Import and Export (General) Regulations (Cap.60A)

Notifying member
Hong Kong, China
Title
Import and Export (General) Regulations (Cap.60A)
First published
01/01/1972
First EIF
Latest published
01/04/2017
In force to
Latest notification
G/LIC/N/3/HKG/27
List of products subject to licensing
Nature of licensing

Non-automatic

Administrative purpose/measure being implemented
  • Other
Decription of purpose/measure being implemented

The import licensing procedure aims to establish a mechanism to regulate, inter alia, the import of the proprietary Chinese medicines and 36 Chinese herbal medicines into Hong Kong Special Administrative Region.

Administrative body(ies) for submission of applications
Chinese Medicines Section, Chinese Medicine Division, Department of Health
16/F, AIA Kowloon Tower, Landmark East, 100 How Ming Street, Kwun Tong, Kowloon, Hong Kong, China
Contact point for information on eligibility

Same as the "Administrative bodies"

Expected duration of licensing procedure
Two working days after submission of application for the import licence, subject to the availability of sufficient information.
Found by secretariat
No
Related document symbols
  • G/LIC/N/2/HKG/4
  • G/LIC/N/2/HKG/5
  • G/LIC/N/2/HKG/24
Source

The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 16 November 2007. It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the consequential amendment to the Import and Export (General) Regulations, Cap. 60A shall come into operation.

Notes
  • G/LIC/N/2/HKG/4


    Any article specified in Sections 2A, 2B and 2C of Part I of the First Schedule of the Import and Export (General) Regulations, Cap. 60A, which are listed below, are subject to import licensing procedures:


    - 31 Chinese herbal medicines specified in Schedule 1 of the Chinese Medicine Ordinance (Cap 549)


    - 5 Chinese herbal medicines specified in Schedule 2 of the Chinese Medicine Ordinance (Cap 549), namely, Flos Campsis, Processed Radix Aconiti, Processed Radix Aconiti Kusnezoffii, Radix Clematidis and Radix Gentianae


    - Proprietary Chinese medicines as defined in Section 2 of the Chinese Medicine Ordinance (Cap 549)


    The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 16 November 2007. It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the consequential amendment to the Import and Export (General) Regulations, Cap. 60A shall come into operation.


  • G/LIC/N/2/HKG/5


    Any article specified in Sections 2A, 2B and 2C of Part I of the First Schedule of the Import and Export (General) Regulations, Cap. 60A, which are listed below, are subject to import licensing procedures:


    - 31 Chinese herbal medicines specified in Schedule 1 of the Chinese Medicine Ordinance (Cap 549);


    - 5 Chinese herbal medicines specified in Schedule 2 of the Chinese Medicine Ordinance (Cap 549), namely, Flos Campsis, Processed Radix Aconiti, Processed Radix Aconiti Kusnezoffii, Radix Clematidis and Radix Gentianae;


    - Proprietary Chinese medicines as defined in Section 2 of the Chinese Medicine Ordinance (Cap 549).


    Contact point for information on eligibility


    Chinese Medicines Section, Chinese Medicine Division, Department of Health, 16/F, AIA Kowloon Tower, Landmark East, 100 How Ming Street, Kwun Tong, Kowloon, Hong Kong, China.


    The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 16 November 2007. It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the consequential amendment to the Import and Export (General) Regulations, Cap. 60A shall come into operation.


  • G/LIC/N/2/HKG/24

    Phase 2 of Trade Single Window (TSW)


    Modification of specific details in existing procedures: Providing a one-stop electronic platform for submission of trade documents for licence applications


    Phase 2 of the TSW was launched on 15 May 2023. It covers the following 14 types of trade documents initially:



    • Licence to Export/Re-export for Endangered Species

    • Licence to Import for Endangered Species

    • Permit for Import of Mammals from the Mainland and Animal Products

    • Re-export Certificate for Species of non-Convention on International Trade in Endangered Species of Wild Fauna and Flora or not yet Controlled under the Protection of Endangered Species of Animals and Plants Ordinance (Cap. 586)

    • Special Permit for Import of Animals and Birds from Overseas

    • Special Permit for Import of Dogs and Cats from Overseas

    • Special Permit for Import of Food/Pet Reptiles from Overseas

    • Food Inspection Certificate

    • Health Certificate for Foods of Animal Origin

    • Import Licence for Frozen/Chilled Meat or Poultry

    • Permission for Import of Milk and Milk Beverage/Cream/Frozen Confections

    • Permission for Import of Eggs

    • Permission for Import of Game, Meat and Poultry

    • Permission for Import of Meat or Poultry for the Purpose of Re-export


    It is the Government's plan to further extend the TSW to cover another 14 types of trade documents (see the list annexed to the press release provided in Box 5 above for these 14 types of trade documents).


    The 14 types of trade documents covered in Phase 1 of the TSW (first rolled out in December 2018 and could be found at https://www.tradesinglewindow.hk/portal/en/useful_information/annex_g.html) are in full service.


    The use of the services provided by Phase 1 and Phase 2 of the TSW is voluntary, and trade members may continue to use existing channels provided by relevant government departments for submitting trade documents.